Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Operating Leases (2023 - 2024)

Fennec Pharmaceuticals filings provide 2 years of Operating Leases readings, the most recent being $2000.0 for Q4 2024.

  • On a quarterly basis, Operating Leases changed 0.0% to $2000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $2000.0, a 0.0% change, with the full-year FY2024 number at $2000.0, changed 0.0% from a year prior.
  • Operating Leases hit $2000.0 in Q4 2024 for Fennec Pharmaceuticals, down from $7000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $17000.0 in Q1 2024 to a low of $2000.0 in Q4 2023.